No confirmed SARS-CoV-2 infection (reference group) n = 94,778* | Confirmed SARS-CoV-2 infection in early pregnancy* n = 13,800* | Confirmed SARS-CoV-2 infection within 30 days before or at delivery n = 2,915* | |
---|---|---|---|
Maternal age, mean (SD) | 28.9 (5.90) | 29.6 (5.69) | 29.4 (5.83) |
Education, n (%) | |||
Primary Secondary Higher Unknown | 7,395 (7.8) 38,869 (41.0) 29,922 (31.6) 18,591 (19.6) | 441 (3.2) 5,227 (37.9) 5,221 (37.8) 2,911 (21.1) | 163 (5.6) 1,161 (39.8) 995 (34.2) 594 (20.4) |
Residency, n (%) | |||
Urban Rural Unknown | 68,952 (72.8) 25,750 (27.1) 76 (0.1) | 11,047 (80.0) 2,753 (20.0) 0 (0) | 2,181 (74.9) 734 (25.1) 0 (0) |
BMI at first ANC visit, n (%) | |||
<18.5 18.5–24.9 25–30 >30 | 5,965 (6.6) 52,862 (58.5) 20,577 (22.8) 10,926 (12.1) | 846 (6.3) 7,924 (58.8) 2,997 (22.3) 1,698 (12.6) | 185 (6.6) 1,581 (56.3) 682 (24.3) 361 (12.8) |
Parity, n (%) | |||
Primiparous Multiparous | 36,508 (38.5) 58,270 (61.5) | 5,621 (40.7) 8,179 (59.3) | 1,166 (40.0) 1,749 (60.0) |
Plurality, n (%) | |||
Singleton Multiple | 93,167 (98.3) 1,611 (1.7) | 13,585 (98.4) 215 (1.6) | 2,865 (98.3) 50 (1.7) |
Adherence to ANC**, n (%) | |||
No care Attended | 4,400 (4.6) 90,378 (95.4) | 313 (2.3) 13,487 (97.7) | 85 (2.9) 2,830 (97.1) |
Gestational age during first ANC visit, mean (SD) | 10.1 (4.64) | 9.8 (3.89) | 9.6 (3.65) |
Gestational diabetes, n (%) | |||
Yes No | 143 (0.2) 94,634 (99.8) | 31 (0.2) 13,769 (99.8) | 7 (0.2) 2,906 (99.8) |
Fully vaccinated***, n (%) | |||
Yes No | 5,084 (5.4) 89,694 (94.6) | 1,739 (12.6) 12,057 (87.4) | 310 (10.6) 2,605 (89.4) |